nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxamine—ADRA1A—Signaling Pathways—CXCR4—hematologic cancer	0.000276	0.000276	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PDGFRB—hematologic cancer	0.000276	0.000276	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HDAC2—hematologic cancer	0.000276	0.000276	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—CCL2—hematologic cancer	0.000276	0.000276	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—IL6R—hematologic cancer	0.000275	0.000275	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—PIK3CB—hematologic cancer	0.000274	0.000274	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PDGFRA—hematologic cancer	0.000272	0.000272	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—JAK1—hematologic cancer	0.000271	0.000271	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PRKCG—hematologic cancer	0.000271	0.000271	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—PIK3R1—hematologic cancer	0.000271	0.000271	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CBL—hematologic cancer	0.000269	0.000269	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IL3—hematologic cancer	0.000266	0.000266	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—JAK2—hematologic cancer	0.000263	0.000263	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PIK3CG—hematologic cancer	0.000263	0.000263	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—MAP2K1—hematologic cancer	0.000262	0.000262	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PTPN1—hematologic cancer	0.000262	0.000262	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—GRB2—hematologic cancer	0.000261	0.000261	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PIK3CD—hematologic cancer	0.000261	0.000261	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PDGFA—hematologic cancer	0.00026	0.00026	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PTPN11—hematologic cancer	0.000259	0.000259	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—RASGRP1—hematologic cancer	0.000258	0.000258	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—SYK—hematologic cancer	0.000257	0.000257	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HSP90AA1—hematologic cancer	0.000257	0.000257	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—KITLG—hematologic cancer	0.000257	0.000257	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PIK3CD—hematologic cancer	0.000255	0.000255	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IL2RA—hematologic cancer	0.000253	0.000253	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—IL2—hematologic cancer	0.000251	0.000251	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—STAT5A—hematologic cancer	0.000251	0.000251	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—CREB1—hematologic cancer	0.000251	0.000251	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—TERT—hematologic cancer	0.00025	0.00025	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—PIK3CB—hematologic cancer	0.00025	0.00025	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CDKN2B—hematologic cancer	0.000249	0.000249	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—STAT1—hematologic cancer	0.000248	0.000248	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PIK3R1—hematologic cancer	0.000246	0.000246	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—CCL2—hematologic cancer	0.000245	0.000245	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—IL6R—hematologic cancer	0.000244	0.000244	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PDGFB—hematologic cancer	0.000244	0.000244	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PIK3R1—hematologic cancer	0.000241	0.000241	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CD86—hematologic cancer	0.00024	0.00024	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—JAK2—hematologic cancer	0.000239	0.000239	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—TSC2—hematologic cancer	0.000239	0.000239	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—HES1—hematologic cancer	0.000237	0.000237	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NCOR1—hematologic cancer	0.000236	0.000236	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—JAK2—hematologic cancer	0.000234	0.000234	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—FGF1—hematologic cancer	0.000233	0.000233	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CSF2—hematologic cancer	0.000233	0.000233	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—MAP2K1—hematologic cancer	0.000233	0.000233	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—GRB2—hematologic cancer	0.000232	0.000232	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PIK3CD—hematologic cancer	0.000231	0.000231	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PDGFA—hematologic cancer	0.000231	0.000231	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—FOXO1—hematologic cancer	0.00023	0.00023	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—FGFR3—hematologic cancer	0.00023	0.00023	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—IL2—hematologic cancer	0.00023	0.00023	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PDGFRB—hematologic cancer	0.000229	0.000229	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—KITLG—hematologic cancer	0.000228	0.000228	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MAPK14—hematologic cancer	0.000227	0.000227	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PIK3CB—hematologic cancer	0.000227	0.000227	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PDGFRA—hematologic cancer	0.000226	0.000226	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—JAK1—hematologic cancer	0.000225	0.000225	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PRKCG—hematologic cancer	0.000225	0.000225	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—ESR1—hematologic cancer	0.000223	0.000223	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—STAT5A—hematologic cancer	0.000223	0.000223	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PIK3CB—hematologic cancer	0.000222	0.000222	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CDKN2B—hematologic cancer	0.000221	0.000221	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—FN1—hematologic cancer	0.00022	0.00022	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PIK3R1—hematologic cancer	0.000219	0.000219	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NFKBIA—hematologic cancer	0.000218	0.000218	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—BAD—hematologic cancer	0.000218	0.000218	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NOTCH1—hematologic cancer	0.000216	0.000216	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CD86—hematologic cancer	0.000214	0.000214	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—JAK2—hematologic cancer	0.000212	0.000212	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CD80—hematologic cancer	0.000211	0.000211	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PIK3CG—hematologic cancer	0.000211	0.000211	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—KIT—hematologic cancer	0.000211	0.000211	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—NRAS—hematologic cancer	0.000211	0.000211	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HES1—hematologic cancer	0.000211	0.000211	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IL2RA—hematologic cancer	0.00021	0.00021	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NCOR1—hematologic cancer	0.000209	0.000209	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—IL2—hematologic cancer	0.000209	0.000209	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—TERT—hematologic cancer	0.000208	0.000208	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PTPN11—hematologic cancer	0.000207	0.000207	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CSF2—hematologic cancer	0.000207	0.000207	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—FGF1—hematologic cancer	0.000207	0.000207	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—FOXO1—hematologic cancer	0.000204	0.000204	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—IL2—hematologic cancer	0.000204	0.000204	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PDGFRB—hematologic cancer	0.000204	0.000204	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PDGFB—hematologic cancer	0.000203	0.000203	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—MAPK3—hematologic cancer	0.000202	0.000202	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PIK3CB—hematologic cancer	0.000202	0.000202	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CREB1—hematologic cancer	0.000201	0.000201	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PDGFRA—hematologic cancer	0.000201	0.000201	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—JAK1—hematologic cancer	0.0002	0.0002	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PRKCG—hematologic cancer	0.0002	0.0002	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—BRAF—hematologic cancer	0.000198	0.000198	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—TSC2—hematologic cancer	0.000198	0.000198	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CCL2—hematologic cancer	0.000196	0.000196	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IL6R—hematologic cancer	0.000196	0.000196	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CREBBP—hematologic cancer	0.000196	0.000196	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—FGFR3—hematologic cancer	0.000191	0.000191	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MAPK14—hematologic cancer	0.000189	0.000189	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MAP2K1—hematologic cancer	0.000187	0.000187	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IL2RA—hematologic cancer	0.000187	0.000187	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PIK3CD—hematologic cancer	0.000185	0.000185	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—IL2—hematologic cancer	0.000185	0.000185	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—ESR1—hematologic cancer	0.000185	0.000185	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—TERT—hematologic cancer	0.000185	0.000185	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000184	0.000184	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—FN1—hematologic cancer	0.000183	0.000183	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—KRAS—hematologic cancer	0.000182	0.000182	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NFKBIA—hematologic cancer	0.000181	0.000181	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—BAD—hematologic cancer	0.000181	0.000181	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PDGFB—hematologic cancer	0.00018	0.00018	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NOTCH1—hematologic cancer	0.000179	0.000179	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—FGF2—hematologic cancer	0.000178	0.000178	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—TSC2—hematologic cancer	0.000176	0.000176	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CD80—hematologic cancer	0.000175	0.000175	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PIK3R1—hematologic cancer	0.000175	0.000175	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—KIT—hematologic cancer	0.000175	0.000175	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PIK3CG—hematologic cancer	0.000175	0.000175	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—NRAS—hematologic cancer	0.000175	0.000175	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PTPN11—hematologic cancer	0.000172	0.000172	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—JAK2—hematologic cancer	0.00017	0.00017	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—FGFR3—hematologic cancer	0.000169	0.000169	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MAPK14—hematologic cancer	0.000168	0.000168	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—MAPK3—hematologic cancer	0.000168	0.000168	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—PIK3CA—hematologic cancer	0.000167	0.000167	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CREB1—hematologic cancer	0.000167	0.000167	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MDM2—hematologic cancer	0.000166	0.000166	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—BRAF—hematologic cancer	0.000165	0.000165	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—ESR1—hematologic cancer	0.000165	0.000165	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CCL2—hematologic cancer	0.000163	0.000163	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IL6R—hematologic cancer	0.000163	0.000163	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—FN1—hematologic cancer	0.000162	0.000162	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CREBBP—hematologic cancer	0.000162	0.000162	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PIK3CB—hematologic cancer	0.000162	0.000162	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MTOR—hematologic cancer	0.000162	0.000162	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NFKBIA—hematologic cancer	0.000161	0.000161	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—BAD—hematologic cancer	0.000161	0.000161	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NOTCH1—hematologic cancer	0.000159	0.000159	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CD80—hematologic cancer	0.000156	0.000156	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PIK3CG—hematologic cancer	0.000156	0.000156	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—KIT—hematologic cancer	0.000156	0.000156	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—NRAS—hematologic cancer	0.000156	0.000156	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MAP2K1—hematologic cancer	0.000155	0.000155	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—HRAS—hematologic cancer	0.000154	0.000154	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PIK3CD—hematologic cancer	0.000154	0.000154	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PTPN11—hematologic cancer	0.000153	0.000153	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000152	0.000152	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CDKN1B—hematologic cancer	0.000152	0.000152	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—KRAS—hematologic cancer	0.000151	0.000151	CbGpPWpGaD
Methoxamine—ADRA1D—GPCR downstream signaling—AKT1—hematologic cancer	0.00015	0.00015	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—MAPK3—hematologic cancer	0.000149	0.000149	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CASP3—hematologic cancer	0.000149	0.000149	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IL2—hematologic cancer	0.000148	0.000148	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CREB1—hematologic cancer	0.000148	0.000148	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—IL6—hematologic cancer	0.000148	0.000148	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—FGF2—hematologic cancer	0.000147	0.000147	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—BRAF—hematologic cancer	0.000146	0.000146	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PIK3R1—hematologic cancer	0.000145	0.000145	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CCL2—hematologic cancer	0.000145	0.000145	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CCND1—hematologic cancer	0.000145	0.000145	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IL6R—hematologic cancer	0.000144	0.000144	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—JUN—hematologic cancer	0.000144	0.000144	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CREBBP—hematologic cancer	0.000144	0.000144	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—JAK2—hematologic cancer	0.000141	0.000141	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—CDKN1A—hematologic cancer	0.00014	0.00014	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PTEN—hematologic cancer	0.00014	0.00014	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—PIK3CA—hematologic cancer	0.000138	0.000138	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MDM2—hematologic cancer	0.000138	0.000138	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MAP2K1—hematologic cancer	0.000138	0.000138	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PIK3CD—hematologic cancer	0.000137	0.000137	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MAPK8—hematologic cancer	0.000137	0.000137	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling by GPCR—AKT1—hematologic cancer	0.000136	0.000136	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000135	0.000135	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PIK3CB—hematologic cancer	0.000134	0.000134	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MTOR—hematologic cancer	0.000134	0.000134	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—KRAS—hematologic cancer	0.000134	0.000134	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—EP300—hematologic cancer	0.000133	0.000133	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—FGF2—hematologic cancer	0.000131	0.000131	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—SRC—hematologic cancer	0.00013	0.00013	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PIK3R1—hematologic cancer	0.000129	0.000129	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—HRAS—hematologic cancer	0.000128	0.000128	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—VEGFA—hematologic cancer	0.000126	0.000126	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CDKN1B—hematologic cancer	0.000126	0.000126	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—JAK2—hematologic cancer	0.000125	0.000125	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—STAT3—hematologic cancer	0.000125	0.000125	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—NRAS—hematologic cancer	0.000125	0.000125	CbGpPWpGaD
Methoxamine—ADRA1B—GPCR downstream signaling—AKT1—hematologic cancer	0.000125	0.000125	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CASP3—hematologic cancer	0.000123	0.000123	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IL2—hematologic cancer	0.000123	0.000123	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—PIK3CA—hematologic cancer	0.000123	0.000123	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—IL6—hematologic cancer	0.000123	0.000123	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MDM2—hematologic cancer	0.000122	0.000122	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CCND1—hematologic cancer	0.00012	0.00012	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—JUN—hematologic cancer	0.00012	0.00012	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MAPK3—hematologic cancer	0.000119	0.000119	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MTOR—hematologic cancer	0.000119	0.000119	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PIK3CB—hematologic cancer	0.000119	0.000119	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—CDKN1A—hematologic cancer	0.000116	0.000116	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—MYC—hematologic cancer	0.000116	0.000116	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PTEN—hematologic cancer	0.000116	0.000116	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—TGFB1—hematologic cancer	0.000116	0.000116	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—HRAS—hematologic cancer	0.000114	0.000114	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MAPK8—hematologic cancer	0.000113	0.000113	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling by GPCR—AKT1—hematologic cancer	0.000113	0.000113	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CDKN1B—hematologic cancer	0.000112	0.000112	CbGpPWpGaD
Methoxamine—ADRA1A—GPCR downstream signaling—AKT1—hematologic cancer	0.000111	0.000111	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—EP300—hematologic cancer	0.000111	0.000111	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CASP3—hematologic cancer	0.00011	0.00011	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IL2—hematologic cancer	0.000109	0.000109	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—IL6—hematologic cancer	0.000109	0.000109	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—SRC—hematologic cancer	0.000108	0.000108	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—KRAS—hematologic cancer	0.000107	0.000107	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CCND1—hematologic cancer	0.000107	0.000107	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—JUN—hematologic cancer	0.000106	0.000106	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—VEGFA—hematologic cancer	0.000105	0.000105	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—STAT3—hematologic cancer	0.000104	0.000104	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—NRAS—hematologic cancer	0.000103	0.000103	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—CDKN1A—hematologic cancer	0.000103	0.000103	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PTEN—hematologic cancer	0.000103	0.000103	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MAPK8—hematologic cancer	0.000101	0.000101	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling by GPCR—AKT1—hematologic cancer	0.0001	0.0001	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MAPK3—hematologic cancer	9.9e-05	9.9e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—PIK3CA—hematologic cancer	9.85e-05	9.85e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—EP300—hematologic cancer	9.82e-05	9.82e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—MYC—hematologic cancer	9.63e-05	9.63e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—TGFB1—hematologic cancer	9.61e-05	9.61e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—SRC—hematologic cancer	9.55e-05	9.55e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—TP53—hematologic cancer	9.53e-05	9.53e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—VEGFA—hematologic cancer	9.3e-05	9.3e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—STAT3—hematologic cancer	9.21e-05	9.21e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—NRAS—hematologic cancer	9.19e-05	9.19e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—HRAS—hematologic cancer	9.12e-05	9.12e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—KRAS—hematologic cancer	8.9e-05	8.9e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MAPK3—hematologic cancer	8.8e-05	8.8e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—IL6—hematologic cancer	8.72e-05	8.72e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—MYC—hematologic cancer	8.56e-05	8.56e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—TGFB1—hematologic cancer	8.54e-05	8.54e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—PIK3CA—hematologic cancer	8.18e-05	8.18e-05	CbGpPWpGaD
Methoxamine—ADRA1D—Signaling Pathways—AKT1—hematologic cancer	8.05e-05	8.05e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—TP53—hematologic cancer	7.91e-05	7.91e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—KRAS—hematologic cancer	7.91e-05	7.91e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—HRAS—hematologic cancer	7.57e-05	7.57e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—PIK3CA—hematologic cancer	7.26e-05	7.26e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—IL6—hematologic cancer	7.24e-05	7.24e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—TP53—hematologic cancer	7.03e-05	7.03e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—HRAS—hematologic cancer	6.72e-05	6.72e-05	CbGpPWpGaD
Methoxamine—ADRA1B—Signaling Pathways—AKT1—hematologic cancer	6.68e-05	6.68e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—IL6—hematologic cancer	6.43e-05	6.43e-05	CbGpPWpGaD
Methoxamine—ADRA1A—Signaling Pathways—AKT1—hematologic cancer	5.93e-05	5.93e-05	CbGpPWpGaD
